• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类的膜翅目毒液过敏

Hymenoptera venom allergy in humans.

作者信息

Cichocka-Jarosz Ewa

机构信息

Department of Pediatrics Jagiellonian University Medical College, Krakow, Poland.

出版信息

Folia Med Cracov. 2012;52(3-4):43-60.

PMID:24852686
Abstract

Reactions to Hymenoptera stings may appear as local or systemic responses. According to European data, the incidence of systemic reactions to Hymenoptera stings in the general population is 0.3-7.5%, with the value being 0.3-0.8% in children and 14-43% in beekeepers. The most common systemic allergic (anaphylactic) reactions are caused by honeybees (Apis mellifera), and certain species of wasps in the family Vespidae. Severe generalized immediate-type allergic (anaphylactic) reactions to insect stings are of the highest clinical importance. They affect skin, gastrointestinal tract, respiratory and cardiovascular system. The classification of severity of anaphylactic reaction following insect stings is based on the 4-grade Mueller scale. Crucial in patomechanism of anaphylaxis are specific IgE antibodies directed against the components of the venom, which mediate the activation of mast cells, the main effector cells of anaphylaxis. Therapeutic management in insect venom allergy should be considered in the context of prophylaxis, intervention in case symptoms develop, prevention in the form of venom specific immunotherapy (VIT). There are two steps of VIT 1. Initial dose venom immunotherapy (given according to four protocols which differ the time to reach the maintenance dose) 2. Maintenance dose VIT, usually equal 100 µg. Standard treatment time should span 3-5 years. The main mechanisms of immune tolerance that are initiated by VIT are associated with: 1. a decreased reactivity of effector cells, 2. expansion of T regulatory lymphocytes with IL-10 expression. Therapeutic effectiveness amounts to 90-100% in wasp venom allergy and approximately 80% in bee venom allergy.

摘要

对膜翅目昆虫叮咬的反应可能表现为局部或全身反应。根据欧洲数据,普通人群中对膜翅目昆虫叮咬的全身反应发生率为0.3 - 7.5%,儿童中的发生率为0.3 - 0.8%,养蜂人中的发生率为14 - 43%。最常见的全身过敏(过敏反应)是由蜜蜂(西方蜜蜂)和胡蜂科的某些黄蜂种类引起的。对昆虫叮咬的严重全身性速发型过敏(过敏反应)具有最高的临床重要性。它们会影响皮肤、胃肠道、呼吸系统和心血管系统。昆虫叮咬后过敏反应严重程度的分类基于4级穆勒量表。过敏反应发病机制的关键是针对毒液成分的特异性IgE抗体,这些抗体介导肥大细胞(过敏反应的主要效应细胞)的激活。昆虫毒液过敏的治疗管理应在预防、症状出现时的干预以及毒液特异性免疫疗法(VIT)形式的预防的背景下考虑。VIT有两个步骤:1. 初始剂量毒液免疫疗法(根据四种不同达到维持剂量时间的方案给药)2. 维持剂量VIT,通常等于100μg。标准治疗时间应持续3 - 5年。由VIT引发的免疫耐受的主要机制与:1. 效应细胞反应性降低,2. 具有IL - 10表达的T调节淋巴细胞扩增有关。黄蜂毒液过敏的治疗有效率为90 - 100%,蜜蜂毒液过敏的治疗有效率约为80%。

相似文献

1
Hymenoptera venom allergy in humans.人类的膜翅目毒液过敏
Folia Med Cracov. 2012;52(3-4):43-60.
2
Hymenoptera Venom Allergy: How Does Venom Immunotherapy Prevent Anaphylaxis From Bee and Wasp Stings?膜翅目毒液过敏:蜂类和胡蜂蜇伤的毒液免疫治疗如何预防过敏反应?
Front Immunol. 2019 Aug 21;10:1959. doi: 10.3389/fimmu.2019.01959. eCollection 2019.
3
Hymenoptera venom allergy.膜翅目毒液过敏。
J Dtsch Dermatol Ges. 2010 Feb;8(2):114-27; quiz 128-30. doi: 10.1111/j.1610-0387.2009.07125.x. Epub 2009 Sep 14.
4
[Therapy control of specific hymenoptera venom allergy].[特定膜翅目昆虫毒液过敏的治疗控制]
Laryngorhinootologie. 2010 Dec;89(12):725-8. doi: 10.1055/s-0030-1267972. Epub 2010 Dec 3.
5
Systemic and local reactions of bee venom immunotherapy in Iran.伊朗蜂毒免疫疗法的全身和局部反应
Iran J Allergy Asthma Immunol. 2007 Dec;6(4):203-6.
6
Rush hymenoptera venom immunotherapy is efficacious and safe.速发型膜翅目毒液免疫疗法有效且安全。
J Investig Allergol Clin Immunol. 2006;16(4):232-8.
7
Venom immunotherapy in patients with allergic reactions to insect stings.虫咬过敏患者的毒液免疫疗法。
Expert Rev Clin Immunol. 2018 Jan;14(1):53-59. doi: 10.1080/1744666X.2018.1413350. Epub 2017 Dec 8.
8
Long-Term Follow-Up of Children after Venom Immunotherapy: Low Adherence to Anaphylaxis Guidelines.毒液免疫治疗后儿童的长期随访:对过敏反应指南的依从性较低。
Int Arch Allergy Immunol. 2017;172(3):167-172. doi: 10.1159/000458707. Epub 2017 Apr 6.
9
Immunoblot studies in allergic patients to hymenoptera venom before and during immunotherapy.对膜翅目昆虫毒液过敏患者在免疫治疗前及治疗期间的免疫印迹研究。
Eur Ann Allergy Clin Immunol. 2005 Sep;37(7):273-8.
10
Safety of Ultrarush Venom Immunotherapy: Comparison Between Children and Adults.超急速毒液免疫疗法的安全性:儿童与成人的比较
J Investig Allergol Clin Immunol. 2016;26(1):40-7.

引用本文的文献

1
Cross-sectional and longitudinal validation of the Slovene version of the health-related quality of life questionnaire in patients with Hymenoptera venom allergy (HRQLH-S).膜翅目毒液过敏患者健康相关生活质量问卷斯洛文尼亚语版本(HRQLH-S)的横断面和纵向验证。
BMC Psychol. 2025 Apr 23;13(1):424. doi: 10.1186/s40359-025-02753-6.
2
Pattern of sensitization to yellow jacket venom and expression of recombinant antigen 5 (Ves v 5) from yellow jacket venom.对黄胡蜂毒液的致敏模式及黄胡蜂毒液重组抗原5(Ves v 5)的表达
BMC Immunol. 2025 Mar 6;26(1):14. doi: 10.1186/s12865-025-00689-5.
3
The Prevalence of Self-Reported Systemic Allergic Reaction to Venom in Beekeepers Worldwide: A Systematic Literature Review and Meta-Analysis.
全球养蜂人自述的毒液全身性过敏反应患病率:一项系统文献综述与荟萃分析
Zdr Varst. 2024 Jun 14;63(3):152-159. doi: 10.2478/sjph-2024-0020. eCollection 2024 Sep.
4
Molecular diagnostics and inhibition of cross-reactive carbohydrate determinants in Hymenoptera venom allergy.膜翅目毒液过敏中交叉反应性碳水化合物决定簇的分子诊断与抑制
Clin Transl Allergy. 2023 Mar;13(3):e12230. doi: 10.1002/clt2.12230.
5
A Review of Honeybee Venom Allergens and Allergenicity.蜜蜂毒液过敏原及其变应原性研究综述
Int J Mol Sci. 2021 Aug 4;22(16):8371. doi: 10.3390/ijms22168371.
6
Three valuable peptides from bee and wasp venoms for therapeutic and biotechnological use: melittin, apamin and mastoparan.三种来自蜜蜂和黄蜂毒液的、具有治疗和生物技术用途的珍贵肽:蜂毒肽、蜂毒明肽和马斯托帕兰。
Toxins (Basel). 2015 Apr 1;7(4):1126-50. doi: 10.3390/toxins7041126.